3-(吗啉-4-基羰基)苯胺 | 104775-65-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-(吗啉-4-基羰基)苯胺
• 中文别名: (3-氨基苯基)-4-吗啉-甲酮
• 英文名称: (3-aminophenyl)(morpholino)methanone
• 英文别名: (3-aminophenyl)(morpholin-4-yl)methanone；(3-aminophenyl)-morpholin-4-ylmethanone
• CAS: 104775-65-7
• 化学式: C₁₁H₁₄N₂O₂
• mdl: MFCD00523626
• 分子量: 206.244
• InChiKey: RFFVEVKGZGRRCP-UHFFFAOYSA-N

物化性质

• 密度：
  1.228

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.363
• 拓扑面积：
  55.6
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2934999090
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-[(Morpholin-4-yl)carbonyl]aniline
Synonyms: (3-aminophenyl)(morpholino)methanone

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-[(Morpholin-4-yl)carbonyl]aniline
CAS number: 104775-65-7

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C11 H14 N2 O2
Molecular weight: 206.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-(吗啉-4-基羰基)苯胺 在 三甲基氯硅烷 作用下， 以 乙二醇甲醚 为溶剂， 生成 4-(4-methyl-2-methylamino-thiazol-5-yl)-2-[3-(morpholine-4-carbonyl)-phenylamino]-pyrimidine-5-carbonitrile
  参考文献：
  名称：

  Synthesis, structure–activity relationship and biological evaluation of 2,4,5-trisubstituted pyrimidine CDK inhibitors as potential anti-tumour agents

  摘要：

  A series of 2,4,5-trisubstituted pyrimidines have been synthesised and characterised, which exhibited potent CDK inhibition and anti-proliferative activities. The structure activity relationship is analysed and a rational for CDK9 selectivity is discussed. Compound 9s, possessing appreciable selectivity for CDK9 over other CDKs, is capable of activating caspase 3, reducing the level of Mcl-1 anti-apoptotic protein, and inducing cancer cell apoptosis. Crown Copyright (C) 2013 Published by Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2013.08.052
• 作为产物：
  描述：

  三氯化苄 在 盐酸 、 氯化亚砜 、 硫酸 、 硝酸 、 铁粉 作用下， 以 甲醇 、 乙醚 、 二氯甲烷 、 水 为溶剂， 反应 7.0h， 生成 3-(吗啉-4-基羰基)苯胺
  参考文献：
  名称：

  Synthesis of (3-Aminophenyl)(morpholino)methanone from Benzotrichloride as Precursor

  摘要：

  (3-氨基苯基)(吗啉基)甲酮衍生物是制备活性药物成分的关键中间体。在本合成中，我们选择了苯并三氯作为制备目标分子的前体，这种前体是很容易获得的原材料。本合成法由四个步骤组成，第一步是将三氯化苯硝化，得到偏硝基苯甲酸，再与亚硫酰氯氯化，得到偏硝基苯甲酰氯，与吗啉缩合后，用铁和盐酸进一步还原，形成目标分子。

  DOI：

  10.14233/ajchem.2016.19419

文献信息

• [EN] PYRROLOTRIAZINES AS ALK AND JAK2 INHIBITORS<br/>[FR] PYRROLOTRIAZINES EN TANT QU'INHIBITEURS D'ALK ET DE JAK2
  申请人：CEPHALON INC

  公开号：WO2010071885A1

  公开（公告）日：2010-06-24

  The present invention provides a compound of formula (I) or a salt form thereof, wherein Q1, Q2, Q3, and Q4 are as defined herein. The compound of formula (I) has ALK and/or JAK2 inhibitory activity, and may be used to treat proliferative disorders.

  本发明提供了一种式（I）的化合物或其盐形式，其中Q1、Q2、Q3和Q4如本文所定义。式（I）的化合物具有ALK和/或JAK2抑制活性，并可用于治疗增殖性疾病。
• Chemoselective nitro reduction and hydroamination using a single iron catalyst
  作者：Kailong Zhu、Michael P. Shaver、Stephen P. Thomas

  DOI：10.1039/c5sc04471e

  日期：——

  The reduction and reductive addition (formal hydroamination) of functionalised nitroarenes is reported using a simple and bench-stable iron(III) catalyst and silane. The reduction is chemoselective for nitro groups over an array of reactive functionalities (ketone, ester, amide, nitrile, sulfonyl and aryl halide). The high activity of this earth-abundant metal catalyst also facilitates a follow-on

  据报道，使用简单且稳定的铁（III）催化剂和硅烷可以还原和还原添加官能化的硝基芳烃。还原在一系列反应性官能团（酮，酯，酰胺，腈，磺酰基和芳基卤化物）上对硝基具有化学选择性。这种富含地球的金属催化剂的高活性还促进了硝基芳烃还原加成到烯烃中的后续反应，从而在温和条件下实现了烯烃的高效正式加氢胺化。两种反应均显着改善了催化活性和化学选择性，并且这些催化剂在促进两个具有挑战性的反应中的实用性支持了重要的机理重叠。
• [EN] PEPTIDES, COMPOUNDS, COMPOSITIONS AND METHODS FOR INHIBITING SOX9 DIMERIZATION<br/>[FR] PEPTIDES, COMPOSÉS, COMPOSITIONS ET PROCÉDÉS POUR INHIBER LA DIMÉRISATION DE SOX9
  申请人：BROWN ARTHUR

  公开号：WO2021097552A1

  公开（公告）日：2021-05-27

  The present application provides SOX9 dimerization inhibitor compounds, compositions, and methods of use thereof. In certain aspects, the SOX9 dimerization inhibitor is a peptide comprising a portion of the SOX9 dimerization motif and a TAT protein to support cell entry which is c-terminal to the SOX9 dimerization motif as set forth in SEQ ID NO:3. In other aspects, the SOX9 dimerization inhibitor is a compound of the general formula I (The applicant is kindly asked to please insert chemical structure here) where one A is H and the other is: (please insert second chemical structure here), and the remaining substituents are as defined in the application.

  本申请提供SOX9二聚体化抑制剂化合物、组合物及其使用方法。在某些方面，SOX9二聚体化抑制剂是一种肽，包括SOX9二聚体化基序的一部分和一个TAT蛋白，用于支持细胞进入，该TAT蛋白位于SOX9二聚体化基序的C端，如序列号为3的SEQ ID中所述。在其他方面，SOX9二聚体化抑制剂是一种符合一般式I的化合物（申请人请在此处插入化学结构），其中一个A为H，另一个为：（请在此处插入第二个化学结构），其余取代基如申请中所定义。
• 2,4-Pyrimidinediamine Compounds and Their Uses
  申请人：Singh Rajinder

  公开号：US20150266828A1

  公开（公告）日：2015-09-24

  The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.

  本发明提供了抑制IgE和/或IgG受体信号级联反应的2,4-嘧啶二胺化合物，该级联反应导致化学介质的释放，以及合成这些化合物的中介体和方法，以及在多种情况下使用这些化合物的方法，包括在治疗和预防由脱粒和其他由IgE和/或IgG受体信号级联反应激活引起的化学介质释放所表征、引起或相关的疾病。
• Pyrrolopyrimidine Compounds and Their Uses
  申请人：Brain Christopher Thomas

  公开号：US20090318441A1

  公开（公告）日：2009-12-24

  The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of diseases, particularly pyrrolopyrimidine compounds and derivatives are described which inhibit protein kinases. The organic compounds are useful in treating proliferative disease.

  本申请描述了对治疗、预防及/或改善疾病有用的有机化合物，特别是描述了抑制蛋白激酶的吡咯并嘧啶化合物及其衍生物。这些有机化合物在治疗增殖性疾病中是有用的。